Skip to content

Paravertebral Nerve Blocks in Neonates

Paravertebral Nerve Blocks in Neonates and Infants Undergoing Repair of Aortic Coarctation, A Pilot Study

Status
Terminated
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03408340
Enrollment
16
Registered
2018-01-24
Start date
2018-07-18
Completion date
2020-07-28
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congenital Heart Disease

Keywords

Anesthesiology, Pediatric surgery, Anesthesia, Regional, Anesthesia, Cardiac Procedures, Nerve Block

Brief summary

This study is a prospective, randomized, non-blinded clinical trial examining the use of paravertebral peripheral nerve block in the neonatal and infant populations. The primary aim of this study is to determine the feasibility of studying whether a single-shot paravertebral nerve block is effective in providing intraoperative and postoperative pain control in infants undergoing a thoracotomy for coarctation of the aorta. This will be determined by comparing consumption of narcotics, expressed as morphine equivalents, in the standard of care and intervention groups.

Detailed description

Pain and pain control remain a major concern in the neonatal and infant populations and pain is often undertreated in order to achieve other goals of medical management. Pain control with narcotic medications create an additional concern as withdrawal from narcotics can become an issue in neonates and infants requiring long-term administration of pain medications. A regional block is an alternative way to control pain by directly blocking the nerves through injecting medication near their course. A paravertebral block (PVB) is a regional block of some of the spinal nerves. The paravertebral space is a wedge shaped space that is located next to the bony structures of the spine. This space is where the nerves of the spine branch out to the body which makes this space an ideal location to deliver numbing drugs for pain. An ultrasound probe is used to ensure that the medicine goes into the paravertebral space. This study will compare the use of the standard of care intravenous pain medication to the use of a PVB. Using a PVB to control pain may also lead to better blood flow to the spinal cord. A Near Infrared Spectroscopy (NIRS) monitor will be used to monitor the oxygen levels in the spine tissues. This study aims to determine if using a paravertebral block in addition to standard of care anesthesia results in better pain control and blood flow to the spine. A total of 30 neonates and infants, defined as children less than 12 months of age, will be enrolled in this study. The subjects will be scheduled for elective or semi-elective cardiac surgery at Children's Healthcare of Atlanta. At the time of surgery they must be greater than or equal to 2.5 kg and undergoing aortic coarctation repair via left thoracotomy. Post-operative pain control in either the control or experimental (paravertebral nerve block) group will be accomplished with intravenous, rectal, and oral analgesics. Patients will receive scheduled rectal acetaminophen while intubated and oral acetaminophen once they have progressed to oral intake of formula. Intravenous fentanyl will be used for breakthrough pain while intubated and until oral intake is tolerated. Once oral intake is resumed, the patient will be provided with oral oxycodone as needed for pain per usual Cardiac Intensive Care Unit (CICU) care. If the patient is not yet ready for extubation and requires additional sedation, intravenous doses of midazolam may be required.

Interventions

Participants will be induced for anesthesia with propofol 3 milligram/kilogram (mg/kg) or ketamine 2mg/kg (if there is intravenous (IV) access) or sevoflurane with 1 microgram/kilogram (mcg/kg) of fentanyl and 1.2 mg/kg rocuronium once IV access is established. A NIRS pad will be used for cerebral oximetry as well as another NIRS pad for spinal cord oximetry. The patient will be intubated and then will be positioned laterally for the nerve block at approximately the left T3-4 level. A linear ultrasound probe with a sterile sheath will be used to provide imaging for the paravertebral nerve block. The injected solution will be 1 milliliter/kilogram (mL/kg) of 0.2% ropivacaine with 5 mcg/mL (1:200,000) epinephrine. Fentanyl may be used as needed for additional analgesia and anesthesia will be maintained with sevoflurane. The skin will not be infiltrated with additional local anesthetic at the conclusion of the case.

DRUGStandard of Care Anesthesia

Participants in this arm will be induced for anesthesia with propofol 3mg/kg or ketamine 2mg/kg (if there is intravenous access) or sevoflurane with 1 mcg/kg of fentanyl and 1.2 mg/kg rocuronium once IV access is established. The patient will be intubated; intravenous and intra-arterial access will be obtained and the patient will be positioned for surgery. Fentanyl may be used as needed for additional analgesia and anesthesia will be maintained with sevoflurane. The skin will be infiltrated at the conclusion of surgery with less than 1 mL/kg of 0.25% bupivacaine with epinephrine 1:200,000.

Sponsors

Emory University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Participants in the study will be randomized to the control arm or experimental arm using computer-generated random assignment, which will be prepared at the start of the study and the assignments held in sealed envelopes. Once the participant is enrolled in the study and consent has been obtained the investigator will open the next consecutive sealed envelope which contains the patient's group assignment (experimental or control).

Eligibility

Sex/Gender
ALL
Age
No minimum to 12 Months
Healthy volunteers
No

Inclusion criteria

* Neonate or Infant (\<12 months age) at the time of surgery * Weigh of 2.5 kilograms or more at the time of surgery * Undergoing aortic coarctation repair via left thoracotomy * Parent or legal guardian willing to participate, and able to understand and sign the provided informed consent

Exclusion criteria

* Intubated prior to surgery (patients who have been intubated and subsequently extubated may be included) * Ongoing septicemia or localized skin infection on the back * Parent or legal guardian unwilling to participate or unable to understand and sign the provided informed consent * Known coagulation defect * Allergy to local anesthetics

Design outcomes

Primary

MeasureTime frameDescription
Morphine Equivalents48 hours after surgeryTo measure total narcotic administration, all narcotics used in the 48-hour postoperative period will be tabulated and converted to morphine equivalents. The total morphine equivalents will be compared between study arms.

Secondary

MeasureTime frameDescription
Near Infrared Spectroscopy (NIRS) ValuesAt the end of surgery up to 5 hoursSpinal cord perfusion will be assessed by continuous measurement of spinal cord near-infrared spectroscopy (NIRS) values during the repair of aortic coarctation, including the aortic cross-clamp period. (NIRS), a non-invasive light probe that measures regional oxygen saturation (rSO2). Decreased spinal cord perfusion (compromised blood flow) is associated with severe morbidities.
Postoperative Ventilation TimeUp to 2 days (typical duration of time in ICU post-surgery)Postoperative ventilation time will be measured as the time, in minutes, until extubation. This time will be compared between study arms.
Time to First FeedingUp to 7 days (typical duration of time until hospital discharge)Return to feeding after surgery will be measured as hours until the first postoperative feeding.
Change in Plasma Epinephrine LevelsBaseline, 24 hours after surgeryStress response to surgery will be evaluated by measuring plasma epinephrine levels at baseline (before incision), postoperatively (just before transfer to the Intensive Care Unit), and 24 hours postoperatively.

Countries

United States

Participant flow

Participants by arm

ArmCount
Paravertebral Nerve Block
Participants in the experimental arm will undergo an anesthetic that includes the regional anesthetic technique, paravertebral nerve block. Paravertebral Nerve Block: Participants will be induced for anesthesia with propofol 3 milligram/kilogram (mg/kg) or ketamine 2mg/kg (if there is intravenous (IV) access) or sevoflurane with 1 microgram/kilogram (mcg/kg) of fentanyl and 1.2 mg/kg rocuronium once IV access is established. A NIRS pad will be used for cerebral oximetry as well as another NIRS pad for spinal cord oximetry. The patient will be intubated, and then will be positioned laterally for the nerve block at approximately the left T3-4 level. A linear ultrasound probe with a sterile sheath will be used to provide imaging for the paravertebral nerve block. The injected solution will be 1 milliliter/kilogram (mL/kg) of 0.2% ropivacaine with 5 mcg/mL (1:200,000) epinephrine. Fentanyl may be used as needed for additional analgesia and anesthesia will be maintained with sevoflurane. The skin will not be infiltrated with additional local anesthetic at the conclusion of the case.
10
Standard of Care Anesthesia
Participants in the control arm will undergo an anesthetic consistent with the standard of care. Standard of Care Anesthesia: Participants in this arm will be induced for anesthesia with propofol 3mg/kg or ketamine 2mg/kg (if there is intravenous access) or sevoflurane with 1 mcg/kg of fentanyl and 1.2 mg/kg rocuronium once IV access is established. The patient will be intubated; intravenous and intra-arterial access will be obtained and the patient will be positioned for surgery. Fentanyl may be used as needed for additional analgesia and anesthesia will be maintained with sevoflurane. The skin will be infiltrated at the conclusion of surgery with less than 1 mL/kg of 0.25% bupivacaine with epinephrine 1:200,000.
6
Total16

Baseline characteristics

CharacteristicStandard of Care AnesthesiaTotalParavertebral Nerve Block
Age, Categorical
<=18 years
6 Participants16 Participants10 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants0 Participants0 Participants
Age, Continuous30.67 days
STANDARD_DEVIATION 32.14
38.56 days
STANDARD_DEVIATION 51.04
43.3 days
STANDARD_DEVIATION 60.8
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants0 Participants0 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
6 Participants16 Participants10 Participants
Race (NIH/OMB)
White
0 Participants0 Participants0 Participants
Region of Enrollment
United States
6 Participants16 Participants10 Participants
Sex: Female, Male
Female
1 Participants6 Participants5 Participants
Sex: Female, Male
Male
5 Participants10 Participants5 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 100 / 6
other
Total, other adverse events
3 / 100 / 6
serious
Total, serious adverse events
0 / 100 / 6

Outcome results

Primary

Morphine Equivalents

To measure total narcotic administration, all narcotics used in the 48-hour postoperative period will be tabulated and converted to morphine equivalents. The total morphine equivalents will be compared between study arms.

Time frame: 48 hours after surgery

ArmMeasureValue (MEAN)Dispersion
Paravertebral Nerve BlockMorphine Equivalents1.86 morphine milligram equivalentsStandard Deviation 1.95
Standard of Care AnesthesiaMorphine Equivalents1.7 morphine milligram equivalentsStandard Deviation 1.96
Secondary

Change in Plasma Epinephrine Levels

Stress response to surgery will be evaluated by measuring plasma epinephrine levels at baseline (before incision), postoperatively (just before transfer to the Intensive Care Unit), and 24 hours postoperatively.

Time frame: Baseline, 24 hours after surgery

ArmMeasureGroupValue (MEAN)Dispersion
Paravertebral Nerve BlockChange in Plasma Epinephrine LevelsBaseline168.3 pg/mLStandard Deviation 105.7
Paravertebral Nerve BlockChange in Plasma Epinephrine Levels24 hours after surgery174 pg/mLStandard Deviation 127.7
Standard of Care AnesthesiaChange in Plasma Epinephrine LevelsBaseline136.8 pg/mLStandard Deviation 79.6
Standard of Care AnesthesiaChange in Plasma Epinephrine Levels24 hours after surgery136.8 pg/mLStandard Deviation 131.4
Secondary

Near Infrared Spectroscopy (NIRS) Values

Spinal cord perfusion will be assessed by continuous measurement of spinal cord near-infrared spectroscopy (NIRS) values during the repair of aortic coarctation, including the aortic cross-clamp period. (NIRS), a non-invasive light probe that measures regional oxygen saturation (rSO2). Decreased spinal cord perfusion (compromised blood flow) is associated with severe morbidities.

Time frame: At the end of surgery up to 5 hours

ArmMeasureGroupValue (MEAN)Dispersion
Paravertebral Nerve BlockNear Infrared Spectroscopy (NIRS) ValuesHead66.74 percentage of rSO2Standard Deviation 11.03
Paravertebral Nerve BlockNear Infrared Spectroscopy (NIRS) ValuesSpinal63.9 percentage of rSO2Standard Deviation 19.76
Standard of Care AnesthesiaNear Infrared Spectroscopy (NIRS) ValuesHead76.1 percentage of rSO2Standard Deviation 11.34
Standard of Care AnesthesiaNear Infrared Spectroscopy (NIRS) ValuesSpinal76.55 percentage of rSO2Standard Deviation 12.72
Secondary

Postoperative Ventilation Time

Postoperative ventilation time will be measured as the time, in minutes, until extubation. This time will be compared between study arms.

Time frame: Up to 2 days (typical duration of time in ICU post-surgery)

ArmMeasureValue (MEAN)Dispersion
Paravertebral Nerve BlockPostoperative Ventilation Time1246 minutesStandard Deviation 728
Standard of Care AnesthesiaPostoperative Ventilation Time1101 minutesStandard Deviation 181
Secondary

Time to First Feeding

Return to feeding after surgery will be measured as hours until the first postoperative feeding.

Time frame: Up to 7 days (typical duration of time until hospital discharge)

ArmMeasureValue (MEAN)Dispersion
Paravertebral Nerve BlockTime to First Feeding24.93 hoursStandard Deviation 6.57
Standard of Care AnesthesiaTime to First Feeding35.27 hoursStandard Deviation 1.83

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026